Workflow
讯飞医疗科技(02506)荣获Wind ESG评级A级:AI医疗领域的可持续发展标杆
XUNFEIHEALTHXUNFEIHEALTH(HK:02506) 智通财经网·2025-07-24 02:38

Core Viewpoint - The company iFlytek Medical Technology has achieved an A-level ESG rating from Wind, reflecting its strong performance in governance, social responsibility, and environmental management, with a score of 7.55, significantly above the industry average of 6.08 [1][4]. Group 1: ESG Rating and Performance - iFlytek Medical Technology ranks 24th among 245 information technology service companies in the ESG rating, showcasing its innovative practices in AI healthcare [1]. - The Wind ESG rating system evaluates companies based on over 500 detailed indicators, assessing their ESG risks and sustainable operational capabilities [4]. Group 2: Social Responsibility - The company emphasizes employee rights and diversity, with a comprehensive compensation and benefits system and anti-discrimination policies, achieving a female employee ratio of 32% [4]. - iFlytek Medical Technology scored 8.04 in information security and privacy protection, significantly higher than the industry average of 3.91, and has obtained ISO 27001 certification [4]. Group 3: Governance - The company has a diverse board policy, with an independent director ratio of 42.86% and a perfect score of 10 in audit mechanisms, contributing to a robust governance structure [4]. - A comprehensive risk management system is in place to ensure compliance and stability in business operations [4]. Group 4: Environmental Initiatives - In 2024, iFlytek Medical will move to a new facility designed around "green and energy-saving" principles, promoting energy efficiency and low-carbon operations [4]. - The company is implementing a series of environmental measures, including paperless offices and green commuting, while enhancing its carbon emission tracking mechanisms [4]. Group 5: Market Outlook - Strong growth in the BC segment is noted, with the application of large models in the medical field expanding market opportunities for the company [5]. - The company is expected to maintain long-term competitiveness in medical AI due to its deep understanding of the Chinese healthcare industry and product synergy across three major terminals [5].